المؤلفون: Forslund, Tomas, Hjemdahl, Paul

المصدر: Svensk Geriatrik. (3):30

المؤلفون: Hellebek, Torben

المصدر: Månedsskrift for Almen Praksis. 91(9):750

المؤلفون: Berntorp, E

المصدر: Information från Läkemedelsverket. 17(2):37

المؤلفون: Bratland, Björn, Hornnes, Magn-Björn

المصدر: Tidsskrift for Den Norske Laegeforening. 134(2):175

المؤلفون: Rundgren, Åke

المصدر: Svensk Geriatrik. (1):22

المؤلفون: Svensson, Roger, Hallmer, Fredrik, Sahöström Englesson, Charlotta, Svensson, Peter J, Becktor, Jonas P

المصدر: Swedish Dental Journal. 37(2):71

المؤلفون: Zia, Elisabet, Holmberg, Petter, Pessah-Rasmussen, Helene

المصدر: Läkartidningen. 110(25-26):1214

المؤلفون: Saarinen, Sini, Puolakka, Jyrki, Boyd, James, Väyrynen, Taneli, Luurila, Harri, Kuisma, Markku

المصدر: Scandinavian Journal of Trauma, Resuscitation & Emergency Medicine. 19(21):1

المؤلفون: Hunjet, Sandra, Podsada, Linda, Bratberg, Kari, Thommesen, Liv

المصدر: Bioingeniören. 46(12):15

المؤلفون: Själander, A, Wallentin, L, Rosenqvist, M, Svensson, P

المصدر: Läkartidningen. 105(37):2478

المؤلفون: Mooe, T

المصدر: Läkartidningen. 105(37):2472

المؤلفون: Anonymous

المصدر: Information från Läkemedelsverket. 16(5):4

المؤلفون: Johansson, B

المصدر: Svensk Sjukhustandläkartidning. 17(3):23

المؤلفون: Samuelsson, Ola, Saeed, Aso

المصدر: Läkartidningen. 114(20-21):949

المؤلفون: Ivan Gornik, Ingrid Prkačin, Višnja Nesek Adam, Vlatko Grabovac, Vanja Giljača, Aljoša Šikić

المصدر: Liječnički vjesnik
Volume 139
Issue 3-4

مصطلحات موضوعية: Antikoagulansi – neželjeni učinci, terapijska primjena, Peroralna primjena, Vitamin K – antagonisti, Varfarin – neželjeni učinci, terapijska primjena, Fibrilacija atrija – farmakoterapija, komplikacije, Moždani udar – etiologija, prevencija, Venska tromboembolija – farmakoterapija, prevencija, Krvarenje – etiologija, prevencija, Glomerularna fi ltracija, Kreatinin – u krvi, Hitna stanja, Prijeoperacijsko zbrinjavanje, Postupnici, Anticoagulants – adverse effects, therapeutic use, Administration, oral, Vitamin K – antagonists and inhibitors, Warfarin – adverse effects, therapeutic use, Atrial fi brillation – complications, drug therapy, Stroke – etiology, prevention and control, Venous thromboembolism – drug therapy, prevention and control, Hemorrhage – etiology, prevention, Glomerular fi ltration rate, Creatinine – blood, Emergencies, Preoperative care, Algorithms

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______951::feef038744f205769c0f02a6ffc6dcf0
https://hrcak.srce.hr/184329

المؤلفون: Else-Marie Bladbjerg, Anja Leppin, Jørgen Jespersen, Jane Skov

المصدر: Skov, J, Bladbjerg, E-M, Leppin, A & Jespersen, J 2013, ' The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment ', Thrombosis Research, vol. 131, no. 2, pp. 125-129 . https://doi.org/10.1016/j.thromres.2012.11.004

مصطلحات موضوعية: Male, medicine.medical_specialty, Genotype, medicine.drug_class, Pharmacology, Biology, Gastroenterology, Aged Alleles Aryl Hydrocarbon Hydroxylases/*genetics Blood Coagulation/*drug effects/genetics Female Genetic Variation Genotype Humans International Normalized Ratio Male Middle Aged Mixed Function Oxygenases/*genetics Prospective Studies Vitamin K Epoxide Reductases Warfarin/adverse effects/*therapeutic use, Mixed Function Oxygenases, Vitamin K Epoxide Reductases, Internal medicine, medicine, Humans, International Normalized Ratio, Prospective Studies, Allele, Blood Coagulation, CYP2C9, Alleles, Aged, Cytochrome P-450 CYP2C9, Anticoagulant, Warfarin, Genetic Variation, Hematology, Middle Aged, Vitamin K antagonist, Female, Aryl Hydrocarbon Hydroxylases, VKORC1, Pharmacogenetics, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b650b644c31fce857c6b6d1a73bf92d
https://doi.org/10.1016/j.thromres.2012.11.004

المؤلفون: Larsen, Christian Iber

المصدر: Hjerteforum. 30(2):69

المؤلفون: Bauersachs, R., Berkowitz, S. D., Brenner, B., Buller, H. R., Decousus, H., Gallus, A. S., Lensing, A. W., Misselwitz, F., Prins, M. H., Raskob, G. E., Segers, A., Verhamme, P., Wells, P., Agnelli, G., Bounameaux, Henri, Cohen, A., Davidson, B. L., Piovella, F., Schellong, S.

المصدر: ISSN: 0028-4793 ; The New England journal of medicine, vol. 363, no. 26 (2010) p. 2499-2510.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Acenocoumarol/adverse effects/therapeutic use, Acute Disease, Administration, Oral, Aged, Anticoagulants/adverse effects/*therapeutic use, Double-Blind Method, Enoxaparin/adverse effects/*therapeutic use, Factor Xa/*antagonists & inhibitors, Female, Hemorrhage/chemically induced, Humans, Injections, Subcutaneous, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Middle Aged, Morpholines/adverse effects/*therapeutic use, Pulmonary Embolism/*drug therapy, Thiophenes/adverse effects/*therapeutic use, Venous Thromboembolism/drug therapy, Venous Thrombosis/*drug therapy, Vitamin K/*antagonists & inhibitors, Warfarin/adverse effects/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/21128814; https://archive-ouverte.unige.ch/unige:20763; unige:20763

الاتاحة: https://archive-ouverte.unige.ch/unige:20763

المؤلفون: Johansson, H

المصدر: Information från Läkemedelsverket. 17(2):20

المؤلفون: Godtfredsen, J

المصدر: Nordisk Geriatrik. (1):6